Table 5 Biodistribution of radioactivity after i.v. injection of 67Ga-DOTA-(D-Asp)14 in micea.
From: Evaluation of Ga-DOTA-(D-Asp)n as bone imaging agents: D-aspartic acid peptides as carriers to bone
Tissue | Time after injection | ||
|---|---|---|---|
10āmin | 60āmin | 180āmin | |
Blood | 2.46 (0.60) | 0.09 (0.04) | 0.03 (0.01) |
Liver | 0.51 (0.12) | 0.15 (0.04) | 0.05 (0.03) |
Kidney | 8.15 (3.86) | 1.21 (0.57) | 0.54 (0.12) |
Small-intestine | 0.55 (0.06) | 0.18 (0.04) | 0.12 (0.02) |
Large-intestine | 0.40 (0.06) | 0.10 (0.01) | 0.20 (0.01) |
Spleen | 0.48 (0.13) | 0.12 (0.03) | 0.12 (0.04) |
Pancreas | 0.88 (0.07) | 0.27 (0.04) | 0.14 (0.06) |
Lung | 1.75 (0.47) | 0.28 (0.09) | 0.03 (0.01) |
Heart | 0.94 (0.16) | 0.18 (0.04) | 0.11 (0.03) |
Stomachb | 0.28 (0.08) | 0.07 (0.01) | 0.06 (0.01) |
Bone (Femur) | 11.90 (2.99) | 13.03 (0.90) | 14.78 (2.34) |
Muscle | 0.77 (0.15) | 0.16 (0.03) | 0.16 (0.11) |
Brain | 0.06 (0.01) | 0.01 (0.01) | 0.01 (0.00) |
F/B ratioc | 4.90 (0.70) | 180.99 (91.94) | 526.37 (130.49) |